Martingale Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.57M | Buy |
24,114
+499
| +2% | +$32.6K | 0.04% | 356 |
|
|
2025
Q1 | $1.58M | Sell |
23,615
-2,562
| -10% | -$172K | 0.04% | 358 |
|
|
2024
Q4 | $1.45M | Sell |
26,177
-8,563
| -25% | -$473K | 0.04% | 387 |
|
|
2024
Q3 | $2.07M | Buy |
34,740
+13,719
| +65% | +$818K | 0.05% | 302 |
|
|
2024
Q2 | $1.34M | Buy |
21,021
+2,590
| +14% | +$165K | 0.03% | 388 |
|
|
2024
Q1 | $1.27M | Buy |
18,431
+1,411
| +8% | +$97.5K | 0.03% | 411 |
|
|
2023
Q4 | $938K | Hold |
17,020
| – | – | 0.02% | 464 |
|
|
2023
Q3 | $988K | Sell |
17,020
-1
| -0% | -$58 | 0.02% | 437 |
|
|
2023
Q2 | $916K | Buy |
17,021
+800
| +5% | +$43.1K | 0.02% | 472 |
|
|
2023
Q1 | $644K | Hold |
16,221
| – | – | 0.01% | 555 |
|
|
2022
Q4 | $653K | Buy |
16,221
+295
| +2% | +$11.9K | 0.01% | 572 |
|
|
2022
Q3 | $513K | Buy |
15,926
+3,100
| +24% | +$99.9K | 0.01% | 617 |
|
|
2022
Q2 | $381K | Buy |
12,826
+2,517
| +24% | +$74.8K | 0.01% | 703 |
|
|
2022
Q1 | $290K | Buy |
10,309
+801
| +8% | +$22.5K | ﹤0.01% | 730 |
|
|
2021
Q4 | $439K | Buy |
+9,508
| New | +$439K | 0.01% | 674 |
|
|
2020
Q4 | – | Sell |
-23,809
| Closed | -$673K | – | 875 |
|
|
2020
Q3 | $673K | Sell |
23,809
-26,700
| -53% | -$755K | 0.01% | 735 |
|
|
2020
Q2 | $1.64M | Sell |
50,509
-4
| -0% | -$129 | 0.02% | 592 |
|
|
2020
Q1 | $2.06M | Buy |
50,513
+10,301
| +26% | +$420K | 0.03% | 482 |
|
|
2019
Q4 | $2.48M | Sell |
40,212
-5,400
| -12% | -$333K | 0.03% | 545 |
|
|
2019
Q3 | $3.33M | Buy |
45,612
+3,001
| +7% | +$219K | 0.03% | 472 |
|
|
2019
Q2 | $3.5M | Buy |
42,611
+15,502
| +57% | +$1.27M | 0.04% | 465 |
|
|
2019
Q1 | $1.91M | Buy |
27,109
+3,800
| +16% | +$268K | 0.02% | 614 |
|
|
2018
Q4 | $1.05M | Buy |
+23,309
| New | +$1.05M | 0.01% | 706 |
|